The CASE adherence index: A novel method for measuring adherence to antiretroviral therapy

S. B. Mannheimer, R. Mukherjee, L. R. Hirschhorn, J. Dougherty, Shivaun Celano, D. Ciccarone, K. K. Graham, J. E. Mantell, L. M. Mundy, Lois Eldred, Michael Botsko, R. Finkelstein

Research output: Contribution to journalArticle

Abstract

The Center for Adherence Support Evaluation (CASE) Adherence Index, a simple composite measure of self-reported antiretroviral therapy (ART) adherence, was compared to a standard three-day self-reported adherence measure among participants in a longitudinal, prospective cross-site evaluation of 12 adherence programs throughout the United States. The CASE Adherence Index, consisting of three unique adherence questions developed for the cross-site study, along with a three-day adherence self-report were administered by interviews every three months over a one-year period. Data from the three cross-site adherence questions (individually and in combination) were compared to three -day self-report data and HIV RNA and CD4 outcomes in cross-sectional analyses. The CASE Adherence Index correlated strongly with the three-day self-reported adherence data (p 10 achieved a 98 cell mean increase in CD4 count over 12 months, compared to a 41 cell increase for those with scores ≥10 (p

Original languageEnglish (US)
Pages (from-to)853-861
Number of pages9
JournalAIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV
Volume18
Issue number7
DOIs
StatePublished - Oct 1 2006

Fingerprint

evaluation
Self Report
Therapeutics
CD4 Lymphocyte Count
Cross-Sectional Studies
HIV
RNA
Interviews
interview

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Health(social science)
  • Health Professions(all)
  • Social Sciences (miscellaneous)

Cite this

The CASE adherence index : A novel method for measuring adherence to antiretroviral therapy. / Mannheimer, S. B.; Mukherjee, R.; Hirschhorn, L. R.; Dougherty, J.; Celano, Shivaun; Ciccarone, D.; Graham, K. K.; Mantell, J. E.; Mundy, L. M.; Eldred, Lois; Botsko, Michael; Finkelstein, R.

In: AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, Vol. 18, No. 7, 01.10.2006, p. 853-861.

Research output: Contribution to journalArticle

Mannheimer, SB, Mukherjee, R, Hirschhorn, LR, Dougherty, J, Celano, S, Ciccarone, D, Graham, KK, Mantell, JE, Mundy, LM, Eldred, L, Botsko, M & Finkelstein, R 2006, 'The CASE adherence index: A novel method for measuring adherence to antiretroviral therapy', AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, vol. 18, no. 7, pp. 853-861. https://doi.org/10.1080/09540120500465160
Mannheimer, S. B. ; Mukherjee, R. ; Hirschhorn, L. R. ; Dougherty, J. ; Celano, Shivaun ; Ciccarone, D. ; Graham, K. K. ; Mantell, J. E. ; Mundy, L. M. ; Eldred, Lois ; Botsko, Michael ; Finkelstein, R. / The CASE adherence index : A novel method for measuring adherence to antiretroviral therapy. In: AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV. 2006 ; Vol. 18, No. 7. pp. 853-861.
@article{beadbcf5388942a8903f53eececbae02,
title = "The CASE adherence index: A novel method for measuring adherence to antiretroviral therapy",
abstract = "The Center for Adherence Support Evaluation (CASE) Adherence Index, a simple composite measure of self-reported antiretroviral therapy (ART) adherence, was compared to a standard three-day self-reported adherence measure among participants in a longitudinal, prospective cross-site evaluation of 12 adherence programs throughout the United States. The CASE Adherence Index, consisting of three unique adherence questions developed for the cross-site study, along with a three-day adherence self-report were administered by interviews every three months over a one-year period. Data from the three cross-site adherence questions (individually and in combination) were compared to three -day self-report data and HIV RNA and CD4 outcomes in cross-sectional analyses. The CASE Adherence Index correlated strongly with the three-day self-reported adherence data (p 10 achieved a 98 cell mean increase in CD4 count over 12 months, compared to a 41 cell increase for those with scores ≥10 (p",
author = "Mannheimer, {S. B.} and R. Mukherjee and Hirschhorn, {L. R.} and J. Dougherty and Shivaun Celano and D. Ciccarone and Graham, {K. K.} and Mantell, {J. E.} and Mundy, {L. M.} and Lois Eldred and Michael Botsko and R. Finkelstein",
year = "2006",
month = "10",
day = "1",
doi = "10.1080/09540120500465160",
language = "English (US)",
volume = "18",
pages = "853--861",
journal = "AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV",
issn = "0954-0121",
publisher = "Routledge",
number = "7",

}

TY - JOUR

T1 - The CASE adherence index

T2 - A novel method for measuring adherence to antiretroviral therapy

AU - Mannheimer, S. B.

AU - Mukherjee, R.

AU - Hirschhorn, L. R.

AU - Dougherty, J.

AU - Celano, Shivaun

AU - Ciccarone, D.

AU - Graham, K. K.

AU - Mantell, J. E.

AU - Mundy, L. M.

AU - Eldred, Lois

AU - Botsko, Michael

AU - Finkelstein, R.

PY - 2006/10/1

Y1 - 2006/10/1

N2 - The Center for Adherence Support Evaluation (CASE) Adherence Index, a simple composite measure of self-reported antiretroviral therapy (ART) adherence, was compared to a standard three-day self-reported adherence measure among participants in a longitudinal, prospective cross-site evaluation of 12 adherence programs throughout the United States. The CASE Adherence Index, consisting of three unique adherence questions developed for the cross-site study, along with a three-day adherence self-report were administered by interviews every three months over a one-year period. Data from the three cross-site adherence questions (individually and in combination) were compared to three -day self-report data and HIV RNA and CD4 outcomes in cross-sectional analyses. The CASE Adherence Index correlated strongly with the three-day self-reported adherence data (p 10 achieved a 98 cell mean increase in CD4 count over 12 months, compared to a 41 cell increase for those with scores ≥10 (p

AB - The Center for Adherence Support Evaluation (CASE) Adherence Index, a simple composite measure of self-reported antiretroviral therapy (ART) adherence, was compared to a standard three-day self-reported adherence measure among participants in a longitudinal, prospective cross-site evaluation of 12 adherence programs throughout the United States. The CASE Adherence Index, consisting of three unique adherence questions developed for the cross-site study, along with a three-day adherence self-report were administered by interviews every three months over a one-year period. Data from the three cross-site adherence questions (individually and in combination) were compared to three -day self-report data and HIV RNA and CD4 outcomes in cross-sectional analyses. The CASE Adherence Index correlated strongly with the three-day self-reported adherence data (p 10 achieved a 98 cell mean increase in CD4 count over 12 months, compared to a 41 cell increase for those with scores ≥10 (p

UR - http://www.scopus.com/inward/record.url?scp=33748710812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748710812&partnerID=8YFLogxK

U2 - 10.1080/09540120500465160

DO - 10.1080/09540120500465160

M3 - Article

C2 - 16971298

AN - SCOPUS:33748710812

VL - 18

SP - 853

EP - 861

JO - AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

JF - AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

SN - 0954-0121

IS - 7

ER -